Disease/Infection News

RSS

Is nirmatrelvir treatment of SARS-CoV-2 associated with a lower risk of post–COVID-19 condition?

Researchers performed an observational cohort study using the US Department of Veterans Affairs healthcare databases.

27 Mar 2023

Study finds persistent decrease in daily step count among U.S. adults post-pandemic

In a recent study published in JAMA Network Open, researchers in Tennessee investigated whether the coronavirus disease 2019 (COVID-19) pandemic altered daily step counts among individuals participating in All of Us (AOU) research programs.

27 Mar 2023

The vital role of patients and the general public in guiding long-COVID research

In a recent study published in the journal Nature Medicine, researchers in the United Kingdom (UK) emphasized the significance of public and patient involvement (PPI) in scientific studies on long coronavirus disease (COVID).

27 Mar 2023

A randomized trial of a blood thinner after severe COVID-19 to prevent clotting events

In a recent prospective study published in the Annals of Internal Medicine Journal, researchers in the United States (US) and Spain performed a randomized controlled trial (RCT) across 127 US hospitals between 2021 and 2022.

27 Mar 2023

Curcumin reduces inflammatory responses in post-COVID vaccinated adults

A new study published in the Nutrients Journal highlights the impact of curcumin supplementation on the immune response following the immunization of Coronavirus disease 2019 (COVID-19) survivors with a primary series of monovalent COVID-19 vaccines.

26 Mar 2023

Incidence of tuberculosis reaches 2.5 cases per 100,00 in the U.S.

The United States (US) Centers for Disease Control and Prevention (CDC) has recently released preliminary data on tuberculosis incidence in the US in 2022. The report is published in the Morbidity and Mortality Weekly Report.

26 Mar 2023

Advancements in understanding and treating breast cancer

Researchers describe recent advancements in breast cancer research.

26 Mar 2023

Tulane receives up to $16 million to move nasal pneumonia vaccine from the lab to clinical trials

The National Institute of Allergy and Infectious Diseases awarded an up to $16 million contract to Tulane University to bring to phase one clinical trial a nasal spray vaccine university researchers invented to thwart antibiotic-resistant Klebsiella pneumoniae, a leading cause of pneumonia.

24 Mar 2023

TTUHSC El Paso scientist receives $2.6 million NIH grant for research on tuberculosis

For over a century, El Paso has long been a sanctuary for individuals suffering from tuberculosis. It will soon be home to groundbreaking research that prevents the debilitating disease.

24 Mar 2023

Substance use disorders not associated with COVID-19-related mortality

New research from Boston Medical Center found that substance use disorders do not increase the likelihood of dying from COVID-19.

24 Mar 2023

Nasally administered molecule effective in preventing all SARS-CoV-2 variants

Researchers have developed a molecule that is, when administered nasally, extremely effective in preventing the disease caused by all known variants of the SARS-CoV-2 virus.

24 Mar 2023

Candida auris escapes innate immunity through metabolic reprogramming

A team of scientists from Australia and Israel demonstrates that Candida auris, a fungus associated with life-threatening and drug-resistant infections, escapes the host's innate immune response by destroying macrophages through metabolic reprogramming. The fungus is also capable of escaping antimicrobial inflammatory response.

23 Mar 2023

High-resolution mass spectrometric rapid identification of Candida auris

A recent study published in the Journal of Fungi used a novel OrbitrapTM high-resolution mass spectrometric technology coupled with liquid chromatography to identify geographically different clades of Candida auris (C. auris) isolates. This proof-of-concept methodology could accurately detect C. auris in the microbiology laboratory.

23 Mar 2023

Candida auris infection without epidemiologic links to a prior outbreak

The Centers for Disease Control and Prevention (CDC) has classified Candida auris (C. auris) as an urgent public threat due to its role in elevating mortality, its ability to persist in hospital environments, and the high possibility of developing pan-drug resistance.

23 Mar 2023

U.S. maternal mortality rates rose during COVID-19 pandemic

A new study examines mortality related to pregnancy during the COVID-19 pandemic as compared pre-pandemic rates.

23 Mar 2023

Hidden "super spreader" spaces associated with a predominance of asymptomatic cases of dengue

For mosquito-borne diseases such as dengue fever, the abundance of the insects in places where people gather has long served as the main barometer for infection risk.

23 Mar 2023

Study reveals the risk factors associated with developing long Covid

Being vaccinated against Covid halves people's risk of developing long Covid, according to new research from the University of East Anglia.

23 Mar 2023

The effects of COVID-19 on stress, depression, and anxiety in pregnant and postpartum women

A recent study published in the journal Midwifery evaluated depression, stress, and anxiety in pregnant and postpartum individuals during the coronavirus disease 2019 (COVID-19) pandemic.

23 Mar 2023

Reinfections with Omicron VOCs occur more frequently and over shorter intervals

In a recent study published in Nature's Communications Biology journal, researchers in the United States of America (USA) employed next-generation sequencing (NGS) data to assess the rise in reinfections with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant.

23 Mar 2023

Candidate hepatitis C mRNA vaccine induces protective immunity in animal model

In a recent study published in the npj vaccines journal, researchers assessed the immune protection elicited by messenger ribonucleic acid (mRNA) vaccines delivering Hepatitis C virus (HCV) E1 and modified E2.

23 Mar 2023

Disease/Infection News

Is nirmatrelvir treatment of SARS-CoV-2 associated with a lower risk of post–COVID-19 condition?

Study finds persistent decrease in daily step count among U.S. adults post-pandemic

The vital role of patients and the general public in guiding long-COVID research

A randomized trial of a blood thinner after severe COVID-19 to prevent clotting events

Curcumin reduces inflammatory responses in post-COVID vaccinated adults

Incidence of tuberculosis reaches 2.5 cases per 100,00 in the U.S.

Advancements in understanding and treating breast cancer

Tulane receives up to $16 million to move nasal pneumonia vaccine from the lab to clinical trials

TTUHSC El Paso scientist receives $2.6 million NIH grant for research on tuberculosis

Substance use disorders not associated with COVID-19-related mortality

Nasally administered molecule effective in preventing all SARS-CoV-2 variants

Candida auris escapes innate immunity through metabolic reprogramming

High-resolution mass spectrometric rapid identification of Candida auris

Candida auris infection without epidemiologic links to a prior outbreak

U.S. maternal mortality rates rose during COVID-19 pandemic

Hidden "super spreader" spaces associated with a predominance of asymptomatic cases of dengue

Study reveals the risk factors associated with developing long Covid

The effects of COVID-19 on stress, depression, and anxiety in pregnant and postpartum women

Reinfections with Omicron VOCs occur more frequently and over shorter intervals

Candidate hepatitis C mRNA vaccine induces protective immunity in animal model

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News